18 results on '"Oliveira, Lucia"'
Search Results
2. How appropriate are answers of online chat-based artificial intelligence (ChatGPT) to common questions on colon cancer?
- Author
-
Emile, Sameh Hany, Horesh, Nir, Freund, Michael, Pellino, Gianluca, Oliveira, Lucia, Wignakumar, Anjelli, and Wexner, Steven D.
- Published
- 2023
- Full Text
- View/download PDF
3. Identifying signatures of the impact of rotavirus vaccines on hospitalizations using sentinel surveillance data from Latin American countries.
- Author
-
Shioda, Kayoko, de Oliveira, Lucia Helena, Sanwogou, Jennifer, Rey-Benito, Gloria, Nuñez Azzad, Diana, Castillo, Roxana Elizabeth, Gamarra Ramírez, María Liz, Von Horoch, Marta Raquel, Weinberger, Daniel M., and Pitzer, Virginia E.
- Subjects
- *
ROTAVIRUSES , *ROTAVIRUS vaccines , *LATIN Americans , *WAVELETS (Mathematics) , *HOSPITAL care , *CENTER of mass - Abstract
• Rotavirus hospitalizations declined after vaccine introduction in PAHO countries. • Changes to rotavirus seasonality occurred post-vaccination and varied by country. • Various methods provide different advantages for quantifying vaccine impact. Passive surveillance data are often the only available source of data that can be used to evaluate the population-level impact of vaccination, but such data often suffer from important limitations such as changes in surveillance efforts. This study provides an example of how to identify important signatures of rotavirus vaccine impact, including evaluating the overall effectiveness and changes in rotavirus seasonal dynamics. We used data from a standardized sentinel rotavirus surveillance network in six Latin American countries (Bolivia, El Salvador, Guatemala, Honduras, Paraguay, and Venezuela) from 2004 to 2017. A random-effects model was used to evaluate changes in the proportion of rotavirus-associated hospitalizations following vaccine introduction. Harmonic regression models were used to estimate vaccine impact on the number of rotavirus hospitalizations, controlling for trends in rotavirus-negative cases. Changes to rotavirus seasonality were evaluated using center of gravity analysis, wavelet analysis, and harmonic regression. All countries observed declines in the proportion of rotavirus-positive acute diarrhea samples with a mean reduction of 16% (95% confidence interval: 10–22%). We estimate that each 10% increase in vaccine coverage was associated with declines in the number of rotavirus-positive cases, ranging from 4.3% (1.3–7.2%) in Honduras to 21.4% (16.8–25.9%) in Venezuela. The strength of the seasonal peak in rotavirus incidence became smaller after vaccine introduction in Guatemala, Honduras, and Venezuela. Seasonal peaks also shifted later in the surveillance year, especially in higher-mortality countries. The combination of methods we applied have different strengths that allow us to identify common signatures of rotavirus vaccine impact. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. Stem cells for Crohn's disease: New perspectives for challenging disorders.
- Author
-
Oliveira, Lucia C.C.
- Published
- 2024
- Full Text
- View/download PDF
5. Parasite species of the endangered Iberian wolf (Canis lupus signatus) and a sympatric widespread carnivore.
- Author
-
Figueiredo, Ana, Oliveira, Lucia, Madeira de Carvalho, Luís, Fonseca, Carlos, and Torres, Rita Tinoco
- Abstract
Parasites have a profound impact on wildlife population dynamics. However, until some years ago, studies on the occurrence and prevalence of wildlife parasites were neglected comparatively with the studies on humans and domestic animals. In this study, we determined the parasite prevalence of two sympatric wild canids: the endangered Iberian wolf ( Canis lupus signatus ) and the widespread red fox ( Vulpes vulpes ), in central Portugal. From November 2014 to July 2015, fresh fecal samples from both species were collected monthly in several transects distributed throughout the study area. All samples were submitted to several coprological techniques. In total, 6 helminth parasites ( Crenosoma vulpis , Angiostrongylus vasorum , Toxocara canis , Trichuris vulpis , Ancylostomatidae, Toxascaris leonina ), and a protozoa ( Balantidium coli ) were identified based on size and morphology. The red fox was infected by seven different parasites while the Iberian wolf was infected by four. All parasites present in wolf were also present in the red fox. C . vulpis had the higher prevalence in red fox, while Ancylostomatidae were the most prevalent parasites in wolf. To our knowledge, this is the first study in this isolated subpopulation of the Iberian wolf. Our results show that both carnivores carry parasites that are of concern as they are pathogenic to humans and other wild and domestic animals. We suggest that surveillance programs must also include monitoring protocols of wildlife; particularly endangered species. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
6. The Effects of High Performance Work Systems and Leader-Member Exchange Quality on Employee Engagement: Evidence from a Brazilian Non-Profit Organization.
- Author
-
Oliveira, Lucia Barbosa de and Silva, Fernanda Flôres Roitman Aguiar da
- Subjects
JOB involvement ,ORGANIZATIONAL performance ,MULTIPLE regression analysis ,NONPROFIT organizations ,BUSINESS enterprises - Abstract
The field of strategic human resource management (SHRM) is mainly concerned with the development of HRM systems that create value to the organization and its internal customers. In this paper, we evaluate the effects of high performance work systems (HPWS) and leader-member exchange (LMX) quality on employee engagement, and also the relationship between employee engagement and turnover intention. The research involved 189 employees of a nonprofit Brazilian organization. Results from hierarchical multiple regression analyses showed that HPWS and LMX quality have a positive and significant effect on employee engagement. It was also shown that engagement has a negative and significant effect on employees’ turnover intention. Implications of these findings are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
7. Fishers as advocates of marine protected areas: a case study from Galicia (NW Spain).
- Author
-
Perez de Oliveira, Lucia
- Subjects
FISHERS ,MARINE parks & reserves ,RECESSIONS ,BIOLOGISTS ,DECISION making ,STAKEHOLDERS - Abstract
Abstract: After years of facing problems such as overfishing, illegal fisheries and the consequences of the Prestige oil spill, the fishermen''s association (cofradia) of Lira, a small town in the coast of Galicia (NW Spain), has pioneered a co-management initiative in the region by proposing the creation of a marine reserve. The proposal was designed and developed by the fishers in partnership with biologists and social scientists, environmentalists and members of the autonomous government of Galicia in a highly participatory process. The views of different stakeholders on the implementation process for the marine reserve were assessed through a programme of semi-structured interviews. These findings were also used to analyse issues related to the implementation process employing a governance analysis framework. It was observed that the inclusion of fishers in the decision-making and the use of their traditional ecological knowledge in the design of the reserve promoted a better understanding of its benefits and an improved compliance with the fishing regulations. The effectiveness of the marine reserve was very high during the first years but it has been recently undermined due to the reduction of financial state support for enforcement in the light of the current economic recession. Whilst this marine reserve was driven by the stakeholders, the prospects depend on an adequate state enforcement capacity. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
8. The Metabolic Profile and Global Cardiovascular Risk in a Cohort of Chronic Heart Failure Outpatients.
- Author
-
Martins, Wolney A., Oliveira, Lucia B., Barros, Luciana N., Abreu, Rosiane S.F., Pereira, Gelsomina A.M., Manhaes, Maria A.R., Camandaroba, Paulo J.P., Sgaraglia, Sergio F., Oliveira, Marli G., Campos, Eugenio P., Quintao, Monica M.P., Cavalcanti, Ana C.D., and Mesquita, Evandro T.
- Published
- 2011
- Full Text
- View/download PDF
9. Influenza and Pneumococcal Vaccination in Heart Failure Patients: A Neglected Recommendation.
- Author
-
Martins, Wolney A., Souza, Renata T., Cabral, Isaias F., Furquim, Thyago A., Ribeiro, Margarete D., Nogueira, Luciana S., Pereira, Gelsomina A., Oliveira, Lucia B., Louback, Flavia, Dadalto, Fernanda, and Camandaroba, Paulo P.
- Published
- 2009
- Full Text
- View/download PDF
10. Human schistosomiasis mansoni: Immune responses during acute and chronic phases of the infection
- Author
-
Caldas, Iramaya Rodrigues, Campi-Azevedo, Ana Carolina, Oliveira, Lucia Fraga Alves, Silveira, Alda Maria Soares, Oliveira, Rodrigo C., and Gazzinelli, Giovanni
- Subjects
- *
IMMUNOGLOBULINS , *IMMUNOLOGY , *DRUG therapy , *APPETITE disorders - Abstract
Abstract: Schistosoma mansoni infection may occur either as an acute infection in individuals who have recently visited an endemic area, with no previous contact with the parasite, or as a lasting chronic disease, if not interrupted by specific chemotherapy. The acute phase is characterized by symptoms such as fever, cough, diarrhea, anorexia, and arthralgias in combination with leukocytosis and eosinophilia, and a high cellular immune response to schistosome antigens especially those from the parasite''s eggs. In the chronic phase, most patients living in endemic areas are asymptomatic, and their immune responses to egg antigens are modulated. A few develop periportal fibrosis of the liver, which may result in the hepatosplenic form of the disease. The humoral response (IgG, IgM and IgE) in acute patients to egg and worm antigens does not differ from the chronic phase. However, a high level of IgG and IgM antibodies to KLH were detected in acute patients. Acute patients express a considerably higher in vitro cellular responsiveness than do chronic patients, especially to egg antigens. They present a mixed profile of Th1 and Th2 cytokines. Ultrasound examinations of endemic population reveal a high heterogeneity between the patients as regards the presence and intensity of periportal fibrosis. Most patients are asymptomatic and their immune responses to schistosoma egg antigens (SEA) are modulated. In contrast, a high percentage of patients with incipient fibrosis (early stage of hepatosplenic) responded strongly to SEA. Patients with advanced hepatosplenic disease were likely to be non-responders to SEA. Most of the chronic patients presented a Th2 profile with low production of interferon-gamma (IFN-γ). The intensity of infection favors the production of interleukin (IL)-10. After adjusting for age, sex, and intensity of infection, a strong correlation was observed between the production of IL-13 and the degree of fibrosis. Chronic asymptomatic patients and those with incipient fibrosis expressed very high levels of heterogeneity of their antibody responses. IgG response to soluble worm antigen preparation (SWAP) was distinct and significantly higher in hepatosplenic patients than in those asymptomatic or with incipient fibrosis. Levels of IgG4 to SEA were significantly higher in sera from patients with incipient fibrosis as compared to uninfected and hepatosplenic groups. Polyclonal idiotypic antibodies and their fragments F(ab′)2, directly stimulate in culture T cells of schistosomiasis patients in presence of IL-1. Polyclonal idiotypic antibodies are able to modulate in vitro granuloma formation around SEA-polyacrylamide. The importance of idiotypes for protection or pathology in schistosomiasis is still not clear. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
11. Immunization stress-related responses presenting as psychogenic non-epileptic seizures following HPV vaccination in Rio Branco, Brazil.
- Author
-
Marchetti, Renato Luiz, Gallucci-Neto, Jose, Kurcgant, Daniela, Proença, Inah Carolina Galatro Faria, Valiengo, Leandro da Costa Lane, Fiore, Lia Arno, Pinto, Lécio Figueira, Maranhão, Ana Goretti Kalume, Oliveira, Maria Tereza da Costa, and de Oliveira, Lucia Helena
- Subjects
- *
HUMAN papillomavirus vaccines , *PSYCHOGENIC nonepileptic seizures , *SEIZURES (Medicine) , *VACCINE safety , *IMMUNIZATION , *MAGNETIC resonance imaging , *PATIENT compliance - Abstract
• ISRR clusters can contribute to reticence to vaccinate. • Clinical manifestations of ISRR include PNES. • PNES in ISRR clusters can be reliably diagnosed by VEEG intensive monitoring. • VEEG can be valuable in critical situations when doubt about PNES in ISRR clusters extends to doctors and lay people. • VEEG can contribute to fighting anti-vaxxer beliefs and consolidate the general public's trust in vaccine safety. The absence of a positive diagnosis of psychogenic non-epileptic seizures (PNES) in immunization stress-related response (ISRR) clusters may have not only a direct impact on affected patients' health but may also reduce compliance to national vaccination programs. It is therefore crucial to develop efficient diagnostic tools and a feasible proposal for proper communication and treatment of ISRR. To explore the psychogenic nature of patients' convulsive seizures in a suspected outbreak of an ISRR cluster following human papillomavirus vaccination in Rio Branco, Brazil. Twelve patients with convulsive seizures were submitted to prolonged intensive video-electroencephalography monitoring, brain magnetic resonance imaging, cerebrospinal fluid diagnostic testing, laboratory subsidiary examinations, and complete neurological and psychiatric evaluations. Ten patients received the positive diagnosis of PNES, and two patients received the diagnosis of idiopathic generalized epilepsy. No biological association was found between the HPV vaccine and the clinical problems presented by the patients. Prolonged VEEG monitoring can contribute significantly to the positive diagnosis of PNES in ISRR clusters and to avoid hesitancy to vaccinate. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
12. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
- Author
-
Suarez, Victor, Michel, Fabiana, Toscano, Cristiana M., Bierrenbach, Ana Luiza, Gonzales, Marco, Alencar, Airlane Pereira, Ruiz Matus, Cuauhtemoc, Andrus, Jon K., and de Oliveira, Lucia H.
- Subjects
- *
PNEUMOCOCCAL vaccines , *JUVENILE diseases , *CHILD mortality , *VACCINATION of children , *PNEUMONIA in children , *CHILDREN , *THERAPEUTICS , *VACCINES - Abstract
Streptococcus pneumoniae is the leading cause of bacterial pneumonia, meningitis and sepsis in children worldwide. Despite available evidence on pneumococcal conjugate vaccine (PCV) impact on pneumonia hospitalizations in children, studies demonstrating PCV impact in morbidity and mortality in middle-income countries are still scarce. Given the disease burden, PCV7 was introduced in Peru in 2009, and then switched to PCV10 in late 2011. National public healthcare system provides care for 60% of the population, and national hospitalization, outpatient and mortality data are available. We thus aimed to assess the effects of routine PCV vaccination on pneumonia hospitalization and mortality, and acute otitis media (AOM) and all cause pneumonia outpatient visits in children under one year of age in Peru. We conducted a segmented time-series analysis using outcome-specific regression models. Study period was from January 2006 to December 2012. Data sources included the National information systems for hospitalization, mortality, outpatient visits, and RENACE, the national database of aggregated weekly notifications of pneumonia and other acute respiratory diseases (both hospitalized and non-hospitalized). Study outcomes included community acquired pneumonia outpatient visits, hospitalizations and deaths (ICD10 codes J12-J18); and AOM outpatient visits (H65-H67). Monthly age- and sex-specific admission, outpatient visit, and mortality rates per 100,000 children aged <1 year, as well as weekly rates for pneumonia and AOM recorded in RENACE were estimated. After PCV introduction, we observed significant vaccine impact in morbidity and mortality in children aged <1 year. Vaccine effectiveness was 26.2% (95% CI 16.9–34.4) for AOM visits, 35% (95% CI 8.6–53.8) for mortality due to pneumonia, and 20.6% (95% CI 10.6–29.5) for weekly cases of pneumonia hospitalization and outpatient visits notified to RENACE. We used secondary data sources which are usually developed for other non-epidemiologic purposes. Despite some data limitations, our results clearly demonstrate the overall benefit of PCV vaccination in Peru. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
13. Catching-up with pentavalent vaccine: Exploring reasons behind lower rotavirus vaccine coverage in El Salvador.
- Author
-
Suarez-Castaneda, Eduardo, Burnett, Eleanor, Elas, Miguel, Baltrons, Rafael, Pezzoli, Lorenzo, Flannery, Brendan, Kleinbaum, David, Oliveira, Lucia Helena de, and Danovaro-Holliday, M. Carolina
- Subjects
- *
ROTAVIRUS vaccines , *PUBLIC health , *HAEMOPHILUS influenzae , *VACCINATION of children , *LOGISTIC regression analysis , *VACCINATION - Abstract
Rotavirus vaccine was introduced in El Salvador in 2006 and is recommended to be given concomitantly with DTP–HepB– Haemophilus influenzae type b (pentavalent) vaccine at ages 2 months (upper age limit 15 weeks) and 4 months (upper age limit 8 months) of age. However, rotavirus vaccination coverage continues to lag behind that of pentavalent vaccine, even in years when national rotavirus vaccine stock-outs have not occurred. We analyzed factors associated with receipt of oral rotavirus vaccine among children who received at least 2 doses of pentavalent vaccine in a stratified cluster survey of children aged 24–59 months conducted in El Salvador in 2011. Vaccine doses included were documented on vaccination cards (94.4%) or in health facility records (5.6%). Logistic regression and survival analysis were used to assess factors associated with vaccination status and age at vaccination. Receipt of pentavalent vaccine by age 15 weeks was associated with rotavirus vaccination (OR: 5.1; 95% CI 2.7, 9.4), and receipt of the second pentavalent dose by age 32 weeks was associated with receipt of two rotavirus vaccine doses (OR: 5.0; 95% CI 2.1–12.3). Timely coverage with the first pentavalent vaccine dose was 88.2% in the 2007 cohort and 91.1% in the 2008 cohort ( p = 0.04). Children born in 2009, when a four-month national rotavirus vaccine stock-out occurred, had an older median age of receipt of rotavirus vaccine and were less likely to receive rotavirus on the same date as the same dose of pentavalent vaccine than children born in 2007 and 2008. Upper age limit recommendations for rotavirus vaccine administration contributed to suboptimal vaccination coverage. Survey data suggest that late rotavirus vaccination and co-administration with later doses of pentavalent vaccine among children born in 2009 helped increase rotavirus vaccine coverage following shortages. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
14. Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries.
- Author
-
Paternina-Caicedo, Angel, Parashar, Umesh D., Alvis-Guzmán, Nelson, De Oliveira, Lucia Helena, Castaño-Zuluaga, Andres, Cotes-Cantillo, Karol, Gamboa-Garay, Oscar, Coronell-Rodríguez, Wilfrido, and De la Hoz-Restrepo, Fernando
- Subjects
- *
ROTAVIRUS vaccines , *DIARRHEA in children , *CHILD mortality , *VACCINATION - Abstract
Background The aim of this study was to estimate the association between rotavirus vaccine (RV) introduction and reduction of all-cause diarrhea death rates among children in five Latin American countries that introduced RV in 2006. Methods Diarrhea mortality data was gathered from 2002 until 2009 from the Pan American Health Organization Mortality Database for five “vaccine adopter” countries (Brazil, El Salvador, Mexico, Nicaragua, and Panama) that introduced RV in 2006 and four “control” countries (Argentina, Chile, Costa Rica, and Paraguay) that did not introduce RV by 2009. Time trend analyses were carried out, and effects and 95% confidence intervals (CI) were estimated. Results Each of the five vaccine adopter countries, except Panama, showed a significant trend in declining mortality rates during the post-vaccine period from 2006 to 2009, whereas no decline was seen in control countries during these years. Furthermore, trends of reduction of all-cause diarrhea mortality in both children <1 year of age and <5 years of age were greater in the post-vaccination period compared with the pre-vaccine period in all vaccine adopter countries (except for Nicaragua), whereas in control countries, a reverse pattern was seen with greater reduction in the early years from 2002 to 2005 versus 2006–2009. An estimatedtotal of 1777 of annual under-5 deaths were avoided in Brazil, El Salvador, Mexico, and Nicaragua during the post-vaccination period. Conclusion All vaccine adopter countries, except Panama, showed a significant decrease in all-cause diarrhea-related deaths after RV implementation, even after adjusting for declining trends over time in diarrhea mortality. These data strongly support continuous efforts to increase vaccination coverage of RV vaccines, particularly in countries with high levels of child mortality from diarrhea. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
15. Strengthening surveillance: Confronting infectious diseases in developing countries
- Author
-
Andrus, Jon Kim, Solorzano, Carlos Castillo, de Oliveira, Lucia, Danovaro-Holliday, M. Carolina, and de Quadros, Ciro A.
- Subjects
- *
COMMUNICABLE diseases , *PUBLIC health surveillance , *PUBLIC health , *SEROTYPES , *EPIDEMICS ,DEVELOPING countries - Abstract
Abstract: Effective management and coordination in regions currently lacking surveillance capacity will require significant increases in existing human resources to manage vitally needed expanded national systems. An adequate investment in human resources is essential for ensuring surveillance functions well. This was the experience in the Americas. By taking this path, other benefits to the overall public health of nations will occur. Monitoring deaths will help as an indicator for impending epidemics or other threats. Better equipped labs will detect antigen shifts in virus and circulating bacterial serotypes more rapidly and other earlier changes in patterns of transmission more efficiently. Any strategy must promote and galvanize the commitment of countries to excellence, equity, and access, above all. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
16. Response to comment on: Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
- Author
-
Toscano, Cristiana M., Suarez, Victor, Michel, Fabiana, Bierrenbach, Ana Luiza, Gonzales, Marco, Alencar, Airlane Pereira, Ruiz Matus, Cuauhtemoc, Andrus, Jon K., and De Oliveira, Lucia H.
- Subjects
- *
PNEUMOCOCCAL vaccines , *JUVENILE diseases - Published
- 2017
- Full Text
- View/download PDF
17. Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: An evaluation using existing data.
- Author
-
Picón, Teresa, Alonso, Lucía, García Gabarrot, Gabriela, Speranza, Noelia, Casas, Mariana, Arrieta, Fernando, Camou, Teresa, Rosa, Raquel, Helena De Oliveira, Lucia, and Verani, Jennifer Rabke
- Subjects
- *
DRUG efficacy , *PNEUMOCOCCAL vaccines , *IMMUNIZATION , *LOGISTIC regression analysis , *PUBLIC health surveillance , *CLINICAL drug trials - Abstract
Abstract: The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced into the routine immunization program in Uruguay in March 2008 with a 2-dose primary series (given at 2 and 4 months) plus a booster (at 12 months) and a catch-up campaign (two doses given at 15 and 17 months). We used a case–control methodology and existing laboratory surveillance and immunization registry data from Uruguay to evaluate PCV7 effectiveness against vaccine-type invasive pneumococcal disease (VT-IPD). Cases of VT-IPD (with pneumococcus obtained from a normally sterile site) were identified through the National Reference Laboratory. Age- and neighborhood-matched controls were obtained through a national immunization registry in which all children are enrolled at birth regardless of vaccine receipt; all eligible controls were included. Immunization status of cases and controls was assessed through the immunization registry, and conditional logistic regression was used to calculate PCV7 effectiveness. Between April 2008 and February 2010, 44 cases of VT-IPD among children<5 years were identified; 43 (98%) of those children were located in the registry. Among located case patients, 7 (16.3%) were age-eligible to have received at least one dose of PCV7. A total of 637 matched controls were included. Vaccine effectiveness was 91.3% (95% CI: 46.4, 98.6) for ≥1 PCV7 doses and 94.8% (95% CI: 43.1, 99.5) for ≥2 PCV7 doses. Using existing data we demonstrated high effectiveness of PCV7 against VT-IPD in Uruguay–a middle-income country using a 2-dose primary series plus a booster dose and a limited catch-up campaign. These data also highlight the utility of surveillance and high-quality immunization registries for evaluating the effectiveness of vaccines. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
18. Rotavirus disease burden, Nicaragua 2001–2005: defining the potential impact of a rotavirus vaccination program
- Author
-
Amador, Juan José, Vasquez, Joshua, Orozco, Maribel, Pedreira, Cristina, Malespin, Omar, Oliveira, Lucia Helena De, Tate, Jacqueline, Parashar, Umesh, and Patel, Manish
- Subjects
- *
ROTAVIRUS vaccines , *DIARRHEA in children , *VACCINATION of children , *GASTROENTERITIS in children , *VIRAL gastroenteritis , *HOSPITAL care , *VACCINATION - Abstract
Summary: Background: In October 2006, a rotavirus vaccine was introduced in Nicaragua for routine immunization of all children. We document the baseline diarrheal disease burden in Nicaragua prior to the vaccine program to facilitate future studies to measure vaccine impact. Methods: We analyzed national data for 2001–2005 on total acute gastroenteritis healthcare visits, hospitalizations, and mortality in Nicaraguan children aged <5 years. Results: Prior to vaccine introduction, by age 5 years, one in four Nicaraguan children required an outpatient consultation, one in 34 were hospitalized, and one in 2487 died from rotavirus-associated diarrhea, representing approximately 41 122 outpatient visits, 4460 hospitalizations, and 60 deaths per year that are preventable through vaccination. Almost half of the total acute gastroenteritis burden was in children <1 year of age. Two distinct seasonal peaks were noted in acute gastroenteritis hospitalizations and deaths. Conclusions: Existing data sources on all-cause acute gastroenteritis could be useful for establishing diarrhea disease burden and monitoring trends after vaccine introduction. Blunting of winter season peaks in rates of diarrhea, particularly among children aged <1–2 years, would be a useful indicator of impact from rotavirus vaccination. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.